Beyond 2 years, CABG with flow assessment was associated with a higher risk for new coronary angiography and new ...

Glucagon-like peptide-1 receptor agonists improve cardiovascular outcomes and reduce mortality in patients with type 2 ...

Among patients with diabetes who underwent PCI after an acute heart attack, those taking a GLP-1 had better survival rates ...

Specialists are debating the best approach in cardiogenic shock after a new analysis of data comparing Impella with ...

Patients hospitalized for heart failure who have cannabis use disorder (CUD) are significantly more likely to experience ...

New findings from multiple studies demonstrate that glucagon-like peptide-1 receptor agonists (GLP-1RAs), a class of ...

Recent studies confirm that precision tools like OCT and AI-guided procedures are not only safer but also more effective in ...

Twin studies predict a 50% spike in heart disease deaths in the next 5 years due to tobacco and marijuana use, with cannabis ...

New clinical results from multiple studies show coronary heart disease death associated with tobacco use is anticipated to rise up to 40% in the next five years and people with cannabis use disorder ...

Consumption of tobacco and marijuana is expected to spike heart disease death by 50pc in the next 5 years, according to twin ...

The CALIPSO randomized clinical trial has demonstrated that OCT-guided stent implantation using a predefined algorithm led to ...

While tobacco use is expected to raise coronary heart disease death by 40 pc, people with cannabis use disorder are 50 pc more likely to experience heart issues ...